Bullfrog AI Holdings, Inc. (BFRG)
- Previous Close
2.8600 - Open
2.9000 - Bid 2.8400 x 100
- Ask 2.9500 x 100
- Day's Range
2.8100 - 2.9600 - 52 Week Range
2.3600 - 8.3500 - Volume
28,428 - Avg. Volume
311,158 - Market Cap (intraday)
22.845M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.8900 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.
www.bullfrogai.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: BFRG
Performance Overview: BFRG
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BFRG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BFRG
Valuation Measures
Market Cap
22.85M
Enterprise Value
19.20M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
270.85
Price/Book (mrq)
8.81
Enterprise Value/Revenue
295.42
Enterprise Value/EBITDA
-3.64
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-234.84%
Return on Equity (ttm)
--
Revenue (ttm)
65k
Net Income Avi to Common (ttm)
-5.36M
Diluted EPS (ttm)
-0.8900
Balance Sheet and Cash Flow
Total Cash (mrq)
2.62M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-4.21M